Sanofi, Regeneron's Praluent Cuts Bad Cholesterol in Studies Ruby Khatun Khatun15 Jun 2017 9:45 AM ISTParis, France and Tarrytown, N.Y.: Sanofi and Regeneron Pharmaceuticals, Inc. announced positive results from two Phase 3b/4 ODYSSEY-DM trials in...
Zydus Cadila gets USFDA nod for ezetimibe tablets Ruby Khatun Khatun14 Jun 2017 11:52 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market ezetimibe tablets used to treat high...
Johnson & Johnson diabetes drug, Invokana shows heart benefit in large safety study Ruby Khatun Khatun14 Jun 2017 11:44 AM ISTJohnson & Johnson's type 2 diabetes drug Invokana significantly reduced the risk of serious heart problems in patients with established heart...
Prices of many essential drugs to rise up to 2.29 percent post-GST Ruby Khatun Khatun14 Jun 2017 11:44 AM ISTNew Delhi: Prices of a majority of essential drugs will increase by up to 2.29 per cent when the Goods and Services Tax regime kicks in from next...
Suven Life Sciences gets patents for anti-neuro degeneration molecule Ruby Khatun Khatun14 Jun 2017 11:43 AM ISTNew Delhi: Drug firm Suven Life Sciences has received one product patent each from Australia and the US for its molecule to be used in the treatment...
Sun Pharma receives USFDA nod for anti-cholesterol drug Ruby Khatun Khatun14 Jun 2017 11:43 AM ISTNew Delhi: Drug major Sun Pharmaceutical Industries' wholly-owned subsidiary has received nod from the US health regulator for its generic version of...
Strides Shasun gets USFDA nod for pain relieving drug Ruby Khatun Khatun13 Jun 2017 12:17 PM ISTNew Delhi: Drug firm Strides Shasun has received the US health regulator's nod for Amantadine Hydrochloride tablets, used in the treatment of...
Bayer, Johnson & Johnson win second US trial over Xarelto bleeding risks Ruby Khatun Khatun13 Jun 2017 12:13 PM ISTA federal jury has cleared Bayer AG and Johnson & Johnson of liability in the second trial to stem from thousands of lawsuits blaming injuries on...
FDA rejects Coherus' biosimilar for Amgen's Neulasta Ruby Khatun Khatun13 Jun 2017 9:12 AM ISTn" style="transform: translate3d(0px, 0px, 0px);"Coherus BioSciences Inc said on Monday the U.S. Food and Drug Administration (FDA) denied the...
Eris Lifesciences enters primary market through IPO Ruby Khatun Khatun12 Jun 2017 3:38 PM ISTMumbai: Eris Lifesciences will be venturing in the primary market on Friday 16th June 2017, with an offer for sale (OFS) of up to 2.89 crore equity...
Zydus Nesher Pharmaceuticals gets FDA nod for antifungal drug Ruby Khatun Khatun12 Jun 2017 11:30 AM ISTNew Delhi: Zydus Group firm Cadila Healthcare said its subsidiary Nesher Pharmaceuticals has received nod from the USFDA to market Nystatin topical...
Biocon, Mylan Present Clinical Data on Insulin Glargine at American Diabetes Associations 77th Scientific Sessions Ruby Khatun Khatun12 Jun 2017 11:29 AM ISTMylan N.V. and Biocon Ltd. announced the presentation of new data from the insulin glargine clinical program, including the INSTRIDE studies at the...
